Published online Jul 16, 2025. doi: 10.4253/wjge.v17.i7.107911
Revised: April 29, 2025
Accepted: June 16, 2025
Published online: July 16, 2025
Processing time: 100 Days and 7.1 Hours
The location of gastric neoplasms can influence the level of technical difficulty and performance of endoscopic submucosal dissection (ESD). There are few studies that analyze the influence of tumor location in the stomach on ESD outcomes.
To compare the clinical efficacy and safety of ESD in the proximal vs distal sto
A retrospective analysis was conducted on patients admitted in chronological order who received gastric ESD between 2009 and 2024. Patients were stratified into two groups based on tumor location: Group 1 included patients with tumors in the lower third of the stomach, while Group 2 included those with tumors in the middle or upper third. The following parameters were evaluated for each group: procedure duration, curative resection rate, en bloc resection rate, complete resection rate, incidence of complications, and depth of neoplastic invasion.
The mean procedure time was 97.07 minutes for lesions located in the distal stomach and 129.08 minutes for those in the proximal stomach (P = 0.0011). En bloc resection rates for ESD in the distal and proximal stomach were 97.9% and 85.7%, respectively (P = 0.0016), while complete resection rates were 93.9% and 73.4%, respectively (P = 0.0002). Curative resection was achieved in 90.9% of distal lesions compared to 65.3% of proximal lesions (P = 0.0001). Submucosal invasion was identified in 4.0% of distal lesions and 14.2% of proximal lesions (P = 0.013).
ESD performed in the proximal stomach requires a longer procedural time compared to ESD in the distal stomach, independent of lesion size and histopathological characteristics. Additionally, proximal gastric ESD is associated with reduced clinical efficacy and increased incidence of submucosal invasion.
Core Tip: The location of gastric neoplasms in endoscopic submucosal dissection (ESD) may affect the level of technical difficulty and the efficacy and safety profile. There is limited scientific evidence assessing the clinical impact of gastric tumor location on ESD outcomes. In tumors in the proximal stomach, it is essential to carefully and individually select those cases that would benefit from gastric ESD eradication.